Rose Pharma ALIAXIN dermal fillers - HSA Registration DE0508845
Access comprehensive regulatory information for Rose Pharma ALIAXIN dermal fillers in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0508845 and owned by Rose Pharma S.A.. The device was registered on January 10, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Aliaxin dermal fillers are intended for the volumetric increase of the tissue for the treatment of cutaneous depressions caused by wrinkles, scarring, and/or volume loss. Aliaxin® EV is indicated for: nasolabial folds, post-traumatic and acne scars, areas of the face which require enrichment of the facial tissue (cheeks, chin, cheekbones) with temporary volumetric increase of the soft tissues. Aliaxin® FL, GP, LV, SR are indicated for: nasolabial folds, wrinkles around the mouth, facial and acne scars, glabellar wrinkles, wrinkles on the forehead, areas of the face which require enrichment of the facial tissue (cheeks, chin, cheekbones, lips) with temporary volumetric increase of the soft tissues.